Responses
Poster Presentations
SLE, Sjögren's and APS - treatment
THU0393 IL-17 Producing Pathogenic T Lymphocytes Co-Express CD20 and are Depleted by Rituximab in Primary sjögren's Syndrome: A Novel Target for an Old Weapon
Compose a Response to This Article
Other responses
No responses have been published for this article.